Home Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
Article Open Access

Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S

  • Zhen Wang ORCID logo , Feng-Lan Zhao , Gui-Ge Hou ORCID logo and Qing-Guo Meng EMAIL logo
Published/Copyright: May 11, 2023

Abstract

C13H18N2O4S, orthorhombic, P212121 (no. 19), a = 6.8619(2) Å, b = 12.0735(4) Å, c = 16.6591(5) Å, V = 1380.16(7) Å3, Z = 4, R gt (F) = 0.0236, wR ref (F 2) = 0.0604, T = 150 K.

CCDC no.: 2232053

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.14 × 0.12 × 0.10 mm
Wavelength: Cu Kα radiation (1.54178 Å)
μ: 2.24 mm−1
Diffractometer, scan mode: φ and ω
θ max, completeness: 79.0°, 99 %
N(hkl)measured, N(hkl)unique, R int: 20,828, 2946, 0.042
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2872
N(param)refined: 183
Programs: Bruker [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.5972 (3) 0.10403 (16) 0.13039 (11) 0.0262 (4)
H1 0.517115 0.168137 0.128250 0.031*
C2 0.5164 (3) 0.00354 (16) 0.15321 (10) 0.0250 (4)
H2 0.381954 −0.000393 0.166545 0.030*
C3 0.6311 (3) −0.09186 (15) 0.15674 (9) 0.0198 (3)
C4 0.8288 (3) −0.08351 (15) 0.13699 (10) 0.0201 (3)
H4 0.909299 −0.147475 0.138953 0.024*
C5 0.9078 (3) 0.01737 (15) 0.11460 (10) 0.0214 (4)
H5 1.042463 0.021778 0.101744 0.026*
C6 0.7935 (3) 0.11253 (15) 0.11059 (10) 0.0224 (4)
C7 0.8846 (3) 0.22168 (16) 0.08884 (10) 0.0261 (4)
H7A 0.786612 0.269128 0.062011 0.031*
H7B 0.993146 0.209151 0.050759 0.031*
C8 1.2917 (3) 0.40152 (16) 0.12293 (10) 0.0227 (4)
H8A 1.314161 0.356074 0.074345 0.027*
H8B 1.375060 0.373634 0.167020 0.027*
C9 1.3305 (3) 0.52418 (16) 0.10640 (11) 0.0252 (4)
H9A 1.465720 0.544398 0.121083 0.030*
H9B 1.308981 0.541944 0.049063 0.030*
C10 1.1842 (3) 0.58433 (15) 0.15935 (10) 0.0207 (3)
H10A 1.160560 0.660597 0.139818 0.025*
H10B 1.229401 0.587452 0.215737 0.025*
C11 1.0013 (2) 0.51285 (13) 0.15131 (9) 0.0177 (3)
H11 0.919980 0.519648 0.200867 0.021*
C12 0.8778 (2) 0.53899 (14) 0.07726 (10) 0.0185 (3)
C13 0.7337 (3) 0.68444 (15) 0.00261 (10) 0.0237 (4)
H13A 0.611150 0.642766 0.001641 0.036*
H13B 0.805258 0.671372 −0.047409 0.036*
H13C 0.705502 0.763671 0.007956 0.036*
N1 0.5498 (2) −0.19452 (12) 0.17535 (9) 0.0238 (3)
H1A 0.437345 −0.187300 0.201944 0.025*
H1B 0.631536 −0.240553 0.194209 0.035*
N2 1.0839 (2) 0.40101 (12) 0.14615 (9) 0.0191 (3)
O1 1.1177 (2) 0.21852 (11) 0.21203 (7) 0.0263 (3)
O2 0.8100 (2) 0.32514 (11) 0.22329 (8) 0.0276 (3)
O3 0.8086 (2) 0.47123 (11) 0.03267 (8) 0.0301 (3)
O4 0.8508 (2) 0.64820 (11) 0.07014 (7) 0.0244 (3)
S1 0.97480 (6) 0.29069 (3) 0.17654 (2) 0.01842 (13)

1 Source of material

(4–Nitrophenyl)methanesulfonyl chloride (2.81 g, 12.0 mmol), methyl pyrrolidine-2-carboxylate hydrochloride (2.39 g, 14.4 mmol) and 4-dimethylaminopyridine (3.52 g, 28.8 mmol) were dissolved in 48 mL of dichloromethane and reacted at room temperature for 3.0 h. The response endpoint was detected by thin layer chromatography (TLC). When the reaction was stopped, an appropriate amount of ethyl acetate was added to the reaction system, stirred and allowed to stand for 10 min. The filtrate obtained after filtering off the precipitate was concentrated under vacuum. The crude product was purified by silica-gel column chromatography (petroleum ether:ethyl acetate = 3:1, v:v). The white solid (1.62 g, 4.94 mmol) obtained after the reaction was dissolved in 20 mL of super-dry methanol with stannous chloride (5.57 g, 24.7 mmol) and refluxed at a controlled temperature of 343 K for 2.0 h. The response endpoint was detected by thin layer chromatography (TLC). When the reaction was stopped, an appropriate amount of saturated aqueous Na2CO3 solution was added to the reaction system, the pH was adjusted to 7–8, an appropriate amount of ethyl acetate was added, and stirred for 1.0 h. The filtrate was obtained by filtration of diatomaceous earth. The filtrate was successively washed with deionized water and brine, dried over anhydrous sodium sulfate and condensed under vacuum. The crude product was purified by silica-gel column chromatography (petroleum ether:ethyl acetate = 2:1, v:v). The title compound was recrystallized from dichloromethane and methanol (1:1, v:v) system to attain suitable crystals.

2 Experimental details

The H atoms were placed in idealized positions and treated as riding on their parent atoms. The H atoms at N1 were placed in difference maps and treated as riding.

3 Comment

Sulfonamides are important compounds with a wide range of applications [35]. The title compound was obtained from the raw material (4-nitrophenyl)methanesulfonyl chloride by substitution and reduction reactions. We further obtained the title compound, methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, as a single crystal.

The ORTEP diagram is presented in the Figure. Bond lengths and angles are all in the expected ranges [6]. The whole molecule contains two parts, p-aminobenzenesulfonyl and methyl L-prolinate, linked by N(2)–S(1). The bond length of N(2)–S(1) is 1.6096(15) Å. The bond angle of C(7)–S(1)–N(2) is 106.80(8)° [7]. For the p-aminobenzenesulfonyl side, the amino group at the C(3) position is obtained by reduction of the nitro group, and can act as a proton donor and form hydrogen bonds with other atoms [8, 9]. For the methyl L-prolinate, the C(11) is the chiral center and the molecule adopts the L stereoselective configuration. The carboxyl methyl ester at the C(11) can improve the molecular lipid solubility.


Corresponding author: Qing-Guo Meng, School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. China, E-mail:

Funding source: Science and Technology Innovation Development Plan of Yantai

Award Identifier / Grant number: 2020XDRH105

Award Identifier / Grant number: 81473104

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by Science and Technology Innovation Development Plan of Yantai (No. 2020XDRH105) and the National Natural Science Foundation of China (No. 81473104).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2 and SAINT Bruker AXS Inc.: Madison, Wisconsin, USA, 2012.Search in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Premakumari, C., Muralikrishna, A., Padmaja, A., Padmavathi, V., Park, S. J., Kim, T. J., Reddy, G. D. Synthesis, antimicrobial and anticancer activities of amido sulfonamido methane linked bis heterocycles. Arab. J. Chem. 2014, 7, 385–395; https://doi.org/10.1016/j.arabjc.2013.10.024.Search in Google Scholar

4. Rubab, L., Afroz, S., Ahmad, S., Hussain, S., Nawaz, I., Irfan, A., Batool, F., Kotwica-Mojzych, K., Mojzych, M. An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents. Molecules 2022, 27, 1604; https://doi.org/10.3390/molecules27051604.Search in Google Scholar PubMed PubMed Central

5. Naicker, T., Brasil, E., Samipillai, M., Govender, T., Baijnath, S. Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino) ethanesulfonamide-toluene (1/0.5), C23.5H23FN2O2S. Z. Kristallogr. N. Cryst. Struct. 2019, 234, 169–171.10.1515/ncrs-2018-0253Search in Google Scholar

6. Gong, Y. X., Geng, Y. D., Zhou, S. J., Wang, G. Y. The crystal structure of 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N- methylmethanaminium 3-carboxyprop-2-enoate, C21H20FN3O6S. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 911–913.Search in Google Scholar

7. Xu, Y. R., Tang, H. J., Xu, Y. J., Guo, J. L., Zhao, X., Meng, Q. G., Xiao, J. H. Design, synthesis, bioactivity evaluation, crystal structures, and in silico studies of new α-amino amide derivatives as potential histone deacetylase 6 inhibitors. Molecules 2022, 27, 3335; https://doi.org/10.3390/molecules27103335.Search in Google Scholar PubMed PubMed Central

8. Krishnan, S., Kaliyaperumal, T., Marimuthu, R., Velusamy, S. Crystal structure, Hirshfeld surface, and DFT studies of 4-((pyrrolidin-1-ylsulfonyl)methyl)aniline. Eur. J. Chem. 2021, 12, 419–431; https://doi.org/10.5155/eurjchem.12.4.419-431.2177.Search in Google Scholar

9. Sridhar, B., Ravikumar, K., Krishnan, H., Singh, A. N. Molecular association of almotriptan with oxalate and terephthalate anions. J. Chem. Crystallogr. 2011, 41, 291–296; https://doi.org/10.1007/s10870-010-9875-7.Search in Google Scholar

Received: 2023-04-10
Accepted: 2023-04-29
Published Online: 2023-05-11
Published in Print: 2023-08-28

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of a polymorph of potassium picrate, C6H2KN3O7
  4. The crystal structure of (1E,2E)-1,2-bis(quinolin-2-ylmethylene)hydrazine, C20H14N4
  5. 5-Amino-2-chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl) benzamide, C11H15O3ClFN3S
  6. Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6
  7. The crystal structure of [N-{[2-(oxy)-4-methoxyphenyl](phenyl)methylidene}alaninato]-diphenyl-silicon(IV) – chloroform (1/1), C29H25NO4Si·CHCl3
  8. Crystal structure of tetracarbonyl-{μ-[N-(diphenylphosphanyl)-N,P,P-triphenylphosphinous amide]}-bis[μ-(phenylmethanethiolato)]diiron (Fe–Fe), C48H39Fe2NO4P2S2
  9. Crystal structure of baryte from Mine du Pradet (France)
  10. The crystal structure of [(2,2′-bipyridine-6-carboxylato-κ3 N,N,O)-(6-phenylpyridine-2-carboxylate-κ2 N,O)copper(II)] monohydrate, C23H17N3O5Cu
  11. Crystal structure of bis(μ-benzeneselenolato)-(μ-[N-benzyl-N-(diphenylphosphanyl)-P,P-diphenylphosphinous amide])-tetracarbonyl diiron (Fe–Fe), C47H37Fe2NO4P2Se2
  12. The crystal structure of diaqua-methanol-κ1 O- (3-thiophenecarboxylato-κO)-(2,2′-dipyridyl-κ2 N,N′)manganese(II) 3-thiophenecarboxylate, C21H22N2O7S2Mn
  13. Crystal structure of catena-poly[tetrakis(butyl)-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O:O,O′,N-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O,N,O′:N′-ditin(IV)], C34H50N6O6Sn2
  14. Crystal structure of 4-chloro-N′-[(1E)-(2-nitrophenyl)methylidene]benzohydrazide, C14H10ClN3O3
  15. The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
  16. The crystal structure of (Z)-4-amino-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H17N3O
  17. The co-crystal structure of etoricoxib–phthalic acid (1/1), C18H15ClN2O2S·C8H6O4
  18. Crystal structure of (glycinto-κ 2 O,N )-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ 4 N,N ,N ,N ]nickel(II) perchlorate monohydrate C18H42ClN5NiO7
  19. The crystal structure of catena-poly[bis(1-ethylimidazole-k1 N)-(μ 2-benzene-1-carboxyl-3,5-dicarboxylato-κ 2 O, O′)zinc(II)], C19H20N4O6Zn
  20. Crystal structure of 3-(thiazol-2-ylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C11H12N2O4S
  21. Rietveld structure analysis of keatite, a rare, metastable SiO2 polymorph
  22. Crystal structure of catena-poly[(μ2-isophthalato-k3 O,O′:O″)(4-(4-pyridyl)-2,5-dipyrazylpyridine-k3 N,N′,N″)cobalt(II)] trihydrate C26H22N6O7Co1
  23. Crystal structure of 3,5–di-O-benzoyl-1,2-O-isopropylidene-α–D-ribose, C22H22O7
  24. The crystal structure of fac-tricarbonyl(6-bromo-2,2-bipyridine-κ2 N,N)-(nitrato-κO)rhenium(I), C13H7BrN3O6Re
  25. The crystal structure of (E)-N′-(4-hydroxy-3-methoxybenzylidene)-2-naphthohydrazide monohydrate, C19H18N2O4
  26. The crystal structure of 5,5′-diselanediyl-bis(2-hydroxybenzaldehyde), C14H10O4Se2
  27. The crystal structure of catena-poly[diaqua-m2-dicyanido-κ2 C:N-dicyanido-κ1 C-bis(4-(pyridin-4-yl)benzaldehyde-κ1N)iron(II)-platinum(II), C28H22N6O4PtFe
  28. Redetermination of the crystal structure of 5,14-dihydro-6,17-dimethyl-8,15-diphenyldibenzo(b,i)(1,4,8,11)tetra-azacyclotetradecine, C32H28N4
  29. Crystal structure of poly[(μ3-2-(3,5-dicarboxyphenyl) benzimidazole-6-carboxylato-κ4O:O:O′:O″)lead(II)] monohydrate, C16H10N2O7Pb
  30. The crystal structure of fac-tricarbonyl(2-pyridin-2-yl-quinoline-κ2 N,N′)-(pyrazole-κN)rhenium(I)nitrate, C20H14N4O3ReNO3
  31. Crystal structure of dibromo-dicarbonyl-bis(tricyclohexylphosphine)-osmium(II) dichloromethane solvate, C38H66Br2O2OsP2
  32. Crystal structure of poly[bis(μ 2-2,6-bis(1-imidazoly)pyridine-κ 2 N:N′)copper(II)] diperchlorate dihydrate, C22H22Cl2CuN10O10
  33. The crystal structure of fac-tricarbonyl(N-benzoyl-N,N-cyclohexylmethylcarbamimidothioato-κ2 S,O)-(pyridine-κN)rhenium(I), C23H24N3O4ReS
  34. Crystal structure of (E)-7-fluoro-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O
  35. Synthesis and crystal structure of 1-((3R,10S,13S, 17S)-3-((2-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO2
  36. The crystal structure of fac-tricarbonyl((pyridin-2-yl)methanamino-κ2 N,N′)-((pyridin-2-yl)methanamino-κN)rhenium(I) nitrate, C15H16O3N4Re
  37. The crystal structure of (1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1-(4-vinylbenzyl)-1H-benzo[d]imidazol-2-yl)methyl)methanamine-κ 4 N,N′,N″,N‴)tris(nitrato-kO,O′)-erbium(III), C29H27ErN8O9
  38. Crystal structure of tetracene-5,12-dione, C18H10O2
  39. Crystal structure of (3R,3aS,6R,6aR)-6-hexyl-3-methyltetrahydrofuro[3,4-b]furan-2,4-dione, C13H20O4
  40. The crystal structure of N1,N3-bis((E)-thiophen-2-ylmethylene)isophthalohydrazide monohydrate, C18H16N4O3S2
  41. Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
  42. Crystal structure of (E)-3-(3-methoxybenzylidene)benzofuran-2(3H)-one, C16H12O3
  43. Synthesis and crystal structure (E)-1-(4-bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one, C11H12BrNO2
  44. Synthesis and crystal structure of (S,E)-4-hydroxy-3-(2-((4aR,6aS,7R,10aS,10bR)-3,3,6a,10b-tetramethyl-8-methylenedecahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)dihydrofuran-2(3H)-one, C23H34O5
  45. The crystal structure of N,N′-(1,2-phenylene)bis (2-((2-oxopropyl)selanyl)benzamide), C26H24N2O4Se2
  46. The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3
  47. The crystal structure of 2-(2-fluorophenyl)naphtho[2,1-d]thiazole, C17H10FNS
  48. Crystal structure of (E)-2,4-di-tert-butyl-6-(((2-fluorophenyl)imino) methyl)phenol, C21H26FNO
  49. Synthesis and crystal structure of 3-methyl-2-(methylthio)-4H-chromen-4-one, C12H12O2S
  50. Crystal structure of dithieno[2,3-d:2′,3′-d′]benzo[1,2-b:4,5-b′]dithiophene-5,10-dione, C14H4O2S4
  51. The crystal structure of dimethyl 2,2ʹ-((adamantane-1,3-diylbis(4,1-phenylene)) bis(oxy))diacetate, C28H32O6
  52. The crystal structure of N-(6-chloro-2-methyl-2H-indazol-5-yl)acetamide, C10H10ClN3O
  53. Crystal structure of triaqua-(5-bromoisophthalato-κ1 O)-(2,2′-bipyridine-κ2 N:N′)nickel(II) hydrate, C18H19BrN2NiO8
  54. The crystal structure of 2-amino-4-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
  55. The crystal structure of catena-poly[5-aminonicotinic acid-k1 N-m2-bromido-copper(I)], Cu(C6N2H6O2)Br
  56. The crystal structure of 2,2-bis(3-methoxyphenyl)-1-tosyl-1,2-dihydro- 4,3λ4  -[1,3,2]diazaborolo[4,5,1-ij]quinoline - dichloromethane (1/1)
  57. The crystal structure of catena-poly[bis(6-phenylpyridine-2-carboxylato-κ2 N,O)-(μ2-4,4′-bipyridne-κ2 N:N)cadmium(II)], C34H24N4O4Cd
  58. The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
  59. Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2
  60. The crystal structure of (E)-N -(2-bromobenzylidene)-2-naphthohydrazide, C36H26Br2N4O2
  61. The crystal structure of 5-nitronaphthoquinone, C10H5NO4
  62. The crystal structure of (S, R p )-4–benzhydrylideneamino-12-(4-tert-butyl oxazolin-2-yl)[2.2]paracyclophane, C36H36N2O
  63. Synthesis and crystal structure of 2-(2-oxo-2-(o-tolyl)ethyl)-4H-chromen-4-one, C18H14O3
  64. Crystal structure of 2-(thiazol-2-yl)hexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, C11H10N2O3S
  65. Crystal structure of N-(diaminomethylene)-1-(dimethylamino)-1-iminiomethanaminium dichloride, C4H13Cl2N5
  66. Crystal structure of poly[(μ3-3, 5-dichloro-2-hydroxy-benzoato-κ4 Cl,O:O′:O″) silver(I)], C7H3AgCl2O3
  67. The crystal structure of tetrakis(1-isopropylimidazole-κ1 N)-[μ2- imidazole-4,5-dicarboxylato-κ4 O,N,O′,N′)]- trioxido-divanadium, C29H41N10O7V2
  68. Crystal structure of catena-[(μ3-bromido)-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N)copper(I)], C9H7BrCuN3O2
  69. The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
Downloaded on 23.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0173/html?srsltid=AfmBOor4n1Cnny14xcD_mBa1_6bvnyOWCG9dZ_ZU98xUofCKmzlKAmFp
Scroll to top button